Dogwood TherapeuticsDWTX
13F holders, Q3 2025 (September 30)12holders +2
3new positions
1sold out
$7.70avg. 13F price*
At the end of Q3 2025, 12 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, up 2 from Q2 2025. 3 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($171K), Geode Capital Management, LLC ($116K) and Tower Research Capital LLC (TRC) ($6K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $878 |
| Exits | 1 | $114 |
All 13F filers, Q2 2025 → Q3 2025: 12,772 shares bought and 17,075 shares sold, net −4,303 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Vanguard Group Inc. | 0.00% | Add +88.2% | 22,179 | $171K |
| Geode Capital Management, LLC | 0.00% | Add +17.6% | 15,084 | $116K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.1% | 744 | $6K |
| Morgan Stanley | 0.00% | Reduce -96.6% | 600 | $5K |
| Activest Wealth Management | 0.00% | No change | 120 | $924 |
| Citigroup Inc. | 0.00% | New | 99 | $762 |
| BlackRock, Inc. | 0.00% | No change | 30 | $231 |
| Bank of America Corp. | 0.00% | Reduce -5.9% | 16 | $123 |
| BNP Paribas Financial Markets | 0.00% | New | 10 | $77 |
| Group One Trading LLC | 0.00% | No change | 9 | $69 |
| Barclays PLC | 0.00% | New | 5 | $39 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -99.3% | 1 | $8 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.